Connection

Marc Bonten to Vaccines, Conjugate

Back to Details
This is a "connection" page, showing publications Marc Bonten has written about Vaccines, Conjugate.
Marc Bonten
Connection Strength
0.470
Vaccines, Conjugate
  1. A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands. Vaccine. 2019 09 10; 37(38):5777-5787.
    View in: PubMed
    Score: 0.151
  2. Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly. Vaccine. 2017 08 03; 35(34):4444-4449.
    View in: PubMed
    Score: 0.140
  3. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Vaccine. 2017 03 01; 35(9):1266-1272.
    View in: PubMed
    Score: 0.138
  4. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands. Vaccine. 2019 07 09; 37(30):4147-4154.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.